153 related articles for article (PubMed ID: 33045097)
1. Unfinished business: Terminated cancer trials and the relevance of treatment intent, sponsors and intervention types.
Buergy D; Riedel J; Sarria GR; Ehmann M; Scafa D; Grilli M; Wenz F; Hofheinz RD
Int J Cancer; 2021 Apr; 148(7):1676-1684. PubMed ID: 33045097
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
Gresham G; Meinert JL; Gresham AG; Meinert CL
JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the frequency, characteristics, and reasons for termination of shoulder- and elbow-related clinical trials.
Caruana DL; Gouzoulis MJ; McLaughlin WM; Grauer JN
J Shoulder Elbow Surg; 2022 Sep; 31(9):1922-1928. PubMed ID: 35398166
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Frequency, Characteristics, and Reasons for Termination of Spine-related Clinical Trials.
Caruana DL; Nam-Woo Kim D; Galivanche AR; David WB; Justen MA; Moushey AM; Sheth AH; Paranjpe MD; Grauer JN
Clin Spine Surg; 2022 Aug; 35(7):E596-E600. PubMed ID: 35351841
[TBL] [Abstract][Full Text] [Related]
5. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
Roumiantseva D; Carini S; Sim I; Wagner TH
Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
[TBL] [Abstract][Full Text] [Related]
6. Publication Rates of Registered Corneal Trials on ClinicalTrials.gov.
Cehelyk EK; Crespo MA; Syed ZA
Cornea; 2024 Mar; 43(3):356-359. PubMed ID: 37404122
[TBL] [Abstract][Full Text] [Related]
7. Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors.
Khunger M; Rakshit S; Hernandez AV; Pasupuleti V; Glass K; Galsky MD; Grivas P
Oncologist; 2018 Dec; 23(12):1494-1499. PubMed ID: 30068783
[TBL] [Abstract][Full Text] [Related]
8. Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination.
Williams RJ; Tse T; DiPiazza K; Zarin DA
PLoS One; 2015; 10(5):e0127242. PubMed ID: 26011295
[TBL] [Abstract][Full Text] [Related]
9. Sponsorship of oncology clinical trials in the United States according to age of eligibility.
Neel DV; Shulman DS; Ma C; Bourgeois F; DuBois SG
Cancer Med; 2020 Jul; 9(13):4495-4500. PubMed ID: 32351000
[TBL] [Abstract][Full Text] [Related]
10. Lack of transparency of clinical trials on endometriosis.
Guo SW; Evers JLH
Obstet Gynecol; 2013 Jun; 121(6):1281-1290. PubMed ID: 23812463
[TBL] [Abstract][Full Text] [Related]
11. Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis.
Rees CA; Pica N; Monuteaux MC; Bourgeois FT
PLoS Med; 2019 Nov; 16(11):e1002966. PubMed ID: 31751330
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Terminated Hand and Wrist-Related Clinical Trials.
Delma S; Foster BK; Baylor JL; Ozdag Y; Manzar S; Langford K; Klena JC; Grandizio LC
J Hand Surg Glob Online; 2023 Sep; 5(5):673-676. PubMed ID: 37790828
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
[TBL] [Abstract][Full Text] [Related]
15. Clinical Trial Outcomes in Urology: Assessing Early Discontinuation, Results Reporting and Publication in ClinicalTrials.Gov Registrations 2007-2019.
Magnani CJ; Steinberg JR; Harmange CI; Zhang X; Driscoll C; Bell A; Larson J; You JG; Weeks BT; Hernandez-Boussard T; Turner BE; Brooks JD
J Urol; 2021 Apr; 205(4):1159-1168. PubMed ID: 33079618
[TBL] [Abstract][Full Text] [Related]
16. Early Termination of Oncology Clinical Trials in the United States.
Zhang E; DuBois SG
Cancer Med; 2023 Mar; 12(5):5517-5525. PubMed ID: 36305832
[TBL] [Abstract][Full Text] [Related]
17. Lack of timely accrual information in oncology clinical trials: a cross-sectional analysis.
Mitchell AP; Hirsch BR; Abernethy AP
Trials; 2014 Mar; 15():92. PubMed ID: 24661848
[TBL] [Abstract][Full Text] [Related]
18. Estimating the rate and reasons of clinical trial failure in urologic oncology.
Stensland KD; DePorto K; Ryan J; Kaffenberger S; Reinstatler LS; Galsky M; Canes D; Skolarus TA; Moinzadeh A
Urol Oncol; 2021 Mar; 39(3):154-160. PubMed ID: 33257221
[TBL] [Abstract][Full Text] [Related]
19. The impact of the COVID-19 pandemic on early termination of ophthalmology clinical trials: A cross-sectional analysis of ClinicalTrials.gov.
Kakkilaya A; Hooda K; Kalva P; Dasara H; Janssen C; Vasireddy S; Ahmed A; Khan S; Kooner K
SAGE Open Med; 2023; 11():20503121231216592. PubMed ID: 38078203
[TBL] [Abstract][Full Text] [Related]
20. Variation in Accrual and Race/Ethnicity Reporting in Urological and Nonurological Related Cancer Trials.
Paul K; Sathianathen N; Dahm P; Le C; Konety BR
J Urol; 2019 Aug; 202(2):385-391. PubMed ID: 31074679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
